查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1963982

細菌菌落計數器市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

Bacterial Colony Counters Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球細菌菌落計數器市場預計將從 2025 年的 4.1587 億美元成長到 2031 年的 5.6791 億美元，複合年成長率達到 5.33%。

這些專用實驗室儀器對於估算營養瓊脂平板上活微生物（例如細菌和真菌）的數量至關重要。該市場的成長主要受以下因素驅動：對嚴格食品安全檢測的需求日益成長，以及製藥和化妝品行業實施的嚴格品管法規。此外，感染疾病控制所需的臨床診斷量不斷增加，也是推動產業成長的重要因素，確保了對不受短期技術潮流影響的、精確的微生物定量工具的穩定需求。

市場概覽
預測期 2027-2031
市場規模：2025年 4.1587億美元
市場規模：2031年 5.6791億美元
複合年成長率：2026-2031年 5.33%
成長最快的細分市場 醫療保健
最大的市場 北美洲

儘管有這些成長趨勢，但自動化計數系統高昂的購買和維修成本仍然是價格敏感型發展中地區採用該系統的一大障礙。關鍵的健康數據凸顯了對經濟實惠且準確的解決方案的迫切需求。世界衛生組織（世衛組織）指出，到2025年，全球六分之一的細菌感染疾病將對標準抗生素治療產生抗藥性，凸顯了提高監測和檢測能力的必要性。因此，儘管資金限制仍然是一個障礙，但加強全球健康監測的迫切需求將繼續支撐市場穩定。

市場促進因素

製藥和生物技術行業的快速成長是全球細菌菌落計數器市場的主要驅動力。隨著生物製藥、疫苗和無菌注射劑產量的增加，對精確微生物限量檢測的需求也隨之成長，以確保產品安全性和符合法規要求。開發平臺的擴展直接轉化為對用於微生物附著量評估的先進計數系統的採購量增加。根據國際藥品製造商協會聯合會（IFPMA）2024年7月發布的《製藥業事實與數據》報告，全球有超過285種疫苗正在研發中，這些疫苗需要在臨床試驗和生產的每個階段進行嚴格的微生物品管，以防止污染並確保疫苗的有效性。

同時，感染疾病和食源性病原體的日益傳播對檢測實驗室提出了更高的檢測能力要求。食品供應鏈中高污染率和抗藥性菌株的出現，使得高效處理不斷成長的檢測量成為必要，因此需要高通量篩檢解決方案。根據歐洲食品安全局 (EFSA) 於 2024 年 12 月發布的《2023 年一體化健康通用感染疾病報告》，2023 年歐盟確診的沙門氏菌病病例同比成長 16.9%，凸顯了健全的病原體監測系統的重要性。對診斷準確性日益成長的需求也反映在主要市場參與者的財務表現中。例如，生物梅里埃公司 (bioMerieux) 報告稱，其微生物部門 2024 年的有機銷售額成長了 8.7%，這主要得益於其試劑和儀器解決方案的持續普及。

市場挑戰

自動化計數系統高昂的初始成本和營運成本是全球細菌菌落計數器市場擴張的主要障礙。雖然自動化設備相比人工計數方法具有更高的準確性和效率，但其高昂的初始投資要求使得許多中小實驗室難以負擔，尤其是在價格敏感的發展中地區。這一經濟壁壘限制了市場滲透率，迫使預算緊張的機構繼續依賴傳統的、勞動密集的人工計數技術。因此，先進數位計數器的普及速度正在放緩，直接影響面向這些分散市場的製造商的產生收入。

日益收緊的報銷機制進一步加劇了這種經濟壓力，限制了檢查室的資本投資。當營運資金緊張時，設備升級往往是首先被推遲的項目。根據美國臨床實驗室協會 (ACLA) 預測，到 2024 年，整個產業約 800 項特定實驗室服務的醫療保險支付金額預計將減少高達 15%。如此大幅度的報銷削減迫使檢查室管理者優先考慮必要的營運成本，而非購買新設備，因此，市場不得不繼續依賴傳統的低成本技術。這將限制自動化菌落計數產業的整體成長軌跡。

市場趨勢

人工智慧 (AI) 和機器學習演算法的融合正在克服傳統像素閾值方法的局限性，並革新菌落計數技術。現代系統利用深度學習神經網路，以前所未有的精確度從瓊脂雜質和殘留物中識別出活菌落，從而降低複雜基質中的假陽性率。隨著檢查室尋求規範判讀流程並最大限度地減少品管過程中的人為誤差，這項技術變革正在迅速普及。根據美國微生物學會 (ASM) 於 2025 年 3 月發布的《2024 年臨床微生物學開放會議論文集》，目前僅有 17% 的臨床檢查室使用 AI 工具進行影像分析，但另有 31% 的實驗室預計將在計畫期結束時採用這些先進的演算法解決方案來提高診斷準確性。

同時，即時動態細菌生長監測技術的引入正在將工作流程從終點分析轉變為連續觀察。動態測量設備整合了培養和成像功能，能夠檢測微菌落出現的瞬間，與靜態人工計數相比，顯著縮短了獲得關鍵無菌檢測結果所需的時間。這種方法能夠在生產環境中快速採取糾正措施，並產生符合嚴格監管資料完整性要求的可靠數位成長曲線。市場財務數據也表明，產業對這種自動化監測系統的依賴性日益增強。根據Rapid Micro Biosystems於2025年11月發布的2025年第三季財報，該公司經常性營收年增32%。這主要歸功於其已部署的自動化監測系統耗材使用量創下歷史新高。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：細菌菌落計數器的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（自動、手動）
    • 按應用領域（醫療、檢測設備、其他）
    • 按最終用戶（製藥和生物技術公司、臨床檢查室、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美細菌菌落計數器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲細菌菌落計數器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區細菌菌落計數器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲細菌菌落計數器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲細菌菌落計數器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球細菌菌落計數器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Instem Group of Companies
  • Thomas Scientific
  • Avantor
  • WIGGENS CO., LTD.
  • bioMerieux SA
  • Microbiology International
  • BioLogics, Inc.
  • Molecular Devices, LLC.
  • Daigger Scientific Inc.
  • Symbiosis

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25347

The Global Bacterial Colony Counters Market is projected to expand from USD 415.87 Million in 2025 to USD 567.91 Million by 2031, achieving a CAGR of 5.33%. These specialized laboratory instruments are essential for estimating the count of viable microorganisms, such as bacteria and fungi, on nutrient agar plates. The market is primarily underpinned by the growing need for rigorous food safety inspections and the strict quality control regulations enforced within the pharmaceutical and cosmetic sectors. Additionally, the increasing volume of clinical diagnostics necessary for infectious disease management serves as a strong driver for industry growth, ensuring a consistent demand for accurate microbial quantification tools that operates independently of temporary technological fads.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 415.87 Million
Market Size 2031USD 567.91 Million
CAGR 2026-20315.33%
Fastest Growing SegmentMedical
Largest MarketNorth America

Despite this growth trajectory, the substantial acquisition and maintenance costs linked to automated counting systems create a significant hurdle to adoption in price-sensitive developing regions. The urgent need for affordable yet precise solutions is highlighted by critical health data. According to the World Health Organization, in 2025, one in six bacterial infections globally was reported as resistant to standard antibiotic treatments, underscoring the necessity for improved surveillance and testing capabilities. Consequently, while financial limitations remain an obstacle, the compelling requirement for enhanced global health monitoring continues to support market stability.

Market Driver

The rapid growth of the pharmaceutical and biotechnology sectors serves as a major catalyst for the Global Bacterial Colony Counters Market. As manufacturers increase the production of biologics, vaccines, and sterile injectables, the demand for precise microbial limit testing to guarantee product safety and regulatory compliance has intensified. This expansion in development pipelines leads directly to increased procurement of advanced counting systems for bioburden estimation. According to the International Federation of Pharmaceutical Manufacturers and Associations, in their July 2024 'Pharmaceutical Industry Facts & Figures' report, there were over 285 vaccines under development globally, a pipeline that demands strict microbiological quality control at every stage of clinical trial and manufacturing to prevent contamination and ensure efficacy.

Simultaneously, the rising prevalence of infectious diseases and foodborne pathogens is compelling laboratories to upgrade their detection capabilities. High rates of contamination in the food supply chain and outbreaks of resistant bacterial strains necessitate high-throughput screening solutions to handle increasing testing volumes efficiently. According to the European Food Safety Authority's December 2024 'European Union One Health 2023 Zoonoses Report', confirmed cases of Salmonellosis in the EU increased by 16.9% in 2023 compared to the previous year, highlighting the critical need for robust pathogen surveillance. This growing demand for diagnostic precision is reflected in the financial performance of key market players; for instance, bioMerieux reported an 8.7% organic sales growth in its microbiology segment in 2024, driven by the continued adoption of reagent and instrument solutions.

Market Challenge

The high acquisition and operational expenses associated with automated counting systems constitute a substantial impediment to the expansion of the Global Bacterial Colony Counters Market. While automated instruments offer superior precision and efficiency compared to manual methods, their initial capital requirements place them out of reach for many small-to-medium-sized laboratories, particularly in price-sensitive developing regions. This financial barrier limits market penetration, as facilities with restricted budgets are forced to continue relying on traditional, labor-intensive manual counting techniques. Consequently, the adoption rate of advanced digital counters slows, directly dampening revenue generation for manufacturers targeting these fragmented market segments.

This economic pressure is further exacerbated by tightening reimbursement structures that constrain laboratory capital expenditures. When operational funds are squeezed, equipment upgrades are often the first line item to be deferred. According to the American Clinical Laboratory Association, in 2024, the industry faced projected Medicare payment reductions of up to 15 percent for nearly 800 specific laboratory services. Such significant contractions in reimbursement levels compel laboratory administrators to prioritize essential operational costs over the procurement of new instrumentation, thereby sustaining the market's reliance on older, less expensive technologies and restricting the overall growth trajectory of the automated colony counter segment.

Market Trends

The integration of Artificial Intelligence and Machine Learning algorithms is reshaping colony counting by addressing the limitations of traditional pixel-thresholding methods. Modern systems utilize deep learning neural networks to distinguish viable microbial colonies from agar impurities or debris with unprecedented accuracy, thereby reducing false-positive rates in complex matrices. This technological shift is rapidly gaining traction as laboratories seek to standardize interpretation and minimize human error in quality control processes. According to the American Society for Microbiology, in the March 2025 'Proceedings of the Clinical Microbiology Open 2024' report, while only 17% of clinical laboratories had currently implemented AI tools for image analysis, an additional 31% anticipated adopting these advanced algorithmic solutions by the end of the planning period to enhance diagnostic precision.

Concurrently, the adoption of Real-Time Kinetic Bacterial Growth Monitoring is transforming the workflow from endpoint analysis to continuous observation. Kinetic instruments integrate incubation and imaging to detect micro-colonies the moment they appear, significantly accelerating time-to-result for critical sterility tests compared to static manual counting. This approach enables faster corrective actions in manufacturing environments and generates robust digital growth curves that satisfy stringent regulatory data integrity requirements. The escalating industrial reliance on this automated surveillance is evident in market financials; according to Rapid Micro Biosystems, in the November 2025 'Third Quarter 2025 Financial Results' report, the company recorded a 32% year-over-year increase in recurring revenue, attributed to the record volume of consumables utilized across its installed base of automated monitoring systems.

Key Market Players

  • Instem Group of Companies
  • Thomas Scientific
  • Avantor
  • WIGGENS CO., LTD.
  • bioMerieux SA
  • Microbiology International
  • BioLogics, Inc.
  • Molecular Devices, LLC.
  • Daigger Scientific Inc.
  • Symbiosis

Report Scope

In this report, the Global Bacterial Colony Counters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bacterial Colony Counters Market, By Type

  • Automatic Type
  • Manual Type

Bacterial Colony Counters Market, By Application

  • Medical
  • Testing Instruments
  • Others

Bacterial Colony Counters Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Others

Bacterial Colony Counters Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bacterial Colony Counters Market.

Available Customizations:

Global Bacterial Colony Counters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bacterial Colony Counters Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Automatic Type, Manual Type)
    • 5.2.2. By Application (Medical, Testing Instruments, Others)
    • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Bacterial Colony Counters Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bacterial Colony Counters Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bacterial Colony Counters Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bacterial Colony Counters Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bacterial Colony Counters Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bacterial Colony Counters Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Bacterial Colony Counters Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bacterial Colony Counters Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bacterial Colony Counters Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bacterial Colony Counters Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Bacterial Colony Counters Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bacterial Colony Counters Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bacterial Colony Counters Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bacterial Colony Counters Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bacterial Colony Counters Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bacterial Colony Counters Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Bacterial Colony Counters Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bacterial Colony Counters Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Bacterial Colony Counters Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Bacterial Colony Counters Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Bacterial Colony Counters Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bacterial Colony Counters Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Bacterial Colony Counters Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Bacterial Colony Counters Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bacterial Colony Counters Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Instem Group of Companies
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thomas Scientific
  • 15.3. Avantor
  • 15.4. WIGGENS CO., LTD.
  • 15.5. bioMerieux SA
  • 15.6. Microbiology International
  • 15.7. BioLogics, Inc.
  • 15.8. Molecular Devices, LLC.
  • 15.9. Daigger Scientific Inc.
  • 15.10. Symbiosis

16. Strategic Recommendations

17. About Us & Disclaimer